Development of an engineered Bacillus subtilis strain for antibiotic‐free sucrose isomerase production

Abstract Sucrose isomerase (SIase) catalyzes the hydrolysis and isomerization of sucrose into isomaltulose, a functional sugar extensively used in the food industry. However, the lack of safe and efficient heterologous expression systems for SIase has constrained its production and application. In this study, an engineered Bacillus subtilis strain for antibiotic‐free SIase production was developed via a food‐grade expression system. First, the B. subtilis strain TEA was modified through the CRISPR/Cas9 system, resulting in a mutant strain TEA4, which exhibited enhanced capabilities for recombinant protein expression. For efficient and safe production of SIase, different constitutive and inducible promoters were evaluated. The maltose‐inducible promoter Poglv was found to have an extracellular SIase activity of 21.7 U mL ‐1 in engineered strain TEA4. Subsequent optimization of the culture medium further increased SIase activity to 26.4 U mL ‐1 during shake flask cultivation. Eventually, using the crude enzyme solution of the engineered strain in biotransformation reactions resulted in a high yield of isomaltulose under high concentrations sucrose, achieving a maximum yield of 83.1%. These findings demonstrated an engineered B. subtilis strain for antibiotic‐free SIase production, paving the way for its scale‐up industrial production and application.